UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Clovis Oncology is implementing good security practices.
Rociletinib is a medication developed to treat non-small cell lung carcinomas with a specific mutation. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
This report shows a preliminary security rating for Clovis Oncology. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Outsourcing, digitization, and globalization have made vendor risk management a top priority for ...
An organization's security posture (or cybersecurity posture) is the collective security status of ...
Compare Clovis Oncology's security performance with other companies